Publisher
Springer Science and Business Media LLC
Subject
Pharmacology (medical),Health Policy,Pharmacology
Reference32 articles.
1. Public Health England. MRSA, MSSA, Gram-negative bacteraemia and CDI: 30-day all-cause fatality 2018-19. 2019. https://www.gov.uk/government/statistics/mrsa-mssa-and-e-coli-bacteraemia-and-c-difficile-infection-30-day-all-cause-fatality#history.
2. Wilcox MH, Ahir H, Coia JE, Dodgson A, Hopkins S, Llewelyn MJ, et al. Impact of recurrent Clostridium difficile infection: hospitalization and patient quality of life. J Antimicrob Chemother. 2017;72(9):2647–56.
3. National Institute for Health and Care Excellence. Vancomycin. 2023. https://bnf.nice.org.uk/drugs/vancomycin/.
4. National Institute for Health and Care Excellence. Teicoplanin. 2023. https://bnf.nice.org.uk/drugs/teicoplanin/.
5. Wilson APGR, Neu H. A critical review of the dosafe of teicoplanin in Europe and the USA. Int J Antimicrob Agents. 1994;4(Suppl 1):1–30.
Cited by
2 articles.
订阅此论文施引文献
订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献